Abstract
Funding The IPCRG provided funding for this research project as an UNLOCK Group study for which the funding was obtained through an unrestricted grant by Novartis AG, Basel, Switzerland. Novartis has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study will include data from the Optimum Patient Care Research Database, and is undertaken in collaboration with Optimum Patient Care and the Respiratory Effectiveness Group, which will provide the data for this initiative without charge to the UNLOCK Group.
Highlights
Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality with high social and economic costs
COPD has been associated with a high prevalence of one or more comorbid conditions, which have an impact on health status and mortality.[2,3,4,5]
A better knowledge of the prevalence and impact of multimorbidity facing COPD patients in primary care would help to evaluate whether a different approach should be taken
Summary
Chronic obstructive pulmonary disease (COPD) is an important cause of morbidity and mortality with high social and economic costs. Cancers, and heart diseases are among the most significant comorbid diseases associated with COPD mortality risk in secondary care settings.[4] Increasing knowledge about COPD comorbidities in primary care is essential for the development of better intervention strategies and for reframing clinical guidelines. This is a unique opportunity to evaluate the impact of individual comorbidities and multimorbidity on COPD patients in primary care in different settings. Is there an association of one or more comorbid conditions with health status and with COPD symptoms in different primary care cohorts?
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
